Suchergebnisse - "Mertens, Daniel"

PubPharm (5)

1

Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors

enthalten in: Blood advances | 2023

von Qi, J. | Endres, S. | Yosifov, D. | +10

CommentOn: N Engl J Med. 2022 Feb 24;386(8):735-743. - PMID 35196427

2

Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes

enthalten in: Neuropathology and applied neurobiology | 2019

von Grasedieck, S. | Mulaw, M. | Sperb, N. | +9

3

Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling

enthalten in: Haematologica | 2016

von Filarsky, K. | Garding, A. | Becker, N. | +9

4

SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)

enthalten in: British journal of haematology | 2010

von Philippen, A. | Diener, S. | Zenz, T. | +3

5

Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells

enthalten in: British journal of haematology | 2010

von Idler, I. | Giannopoulos, K. | Zenz, T. | +5

1
[1]